Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to -$46000.0.

  • Inhibrx Biosciences' Other Non Operating Income fell 21219.51% to -$46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282000.0, marking a year-over-year decrease of 9720.28%. This contributed to the annual value of $75000.0 for FY2024, which is 11293.1% up from last year.
  • As of Q3 2025, Inhibrx Biosciences' Other Non Operating Income stood at -$46000.0, which was down 21219.51% from -$246000.0 recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' Other Non Operating Income peaked at $60000.0 during Q4 2024, and registered a low of -$246000.0 during Q2 2025.
  • Over the past 3 years, Inhibrx Biosciences' median Other Non Operating Income value was -$54500.0 (recorded in 2024), while the average stood at -$77700.0.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 13797.47% in 2024, then plummeted by 84545.45% in 2025.
  • Inhibrx Biosciences' Other Non Operating Income (Quarter) stood at -$158000.0 in 2023, then surged by 137.97% to $60000.0 in 2024, then tumbled by 176.67% to -$46000.0 in 2025.
  • Its Other Non Operating Income stands at -$46000.0 for Q3 2025, versus -$246000.0 for Q2 2025 and -$50000.0 for Q1 2025.